Table 7.
Clinical outcomes in patients with various vaccination conditions.
| Parameters | Full inactivated vaccination (n = 355) | Full recombinant vaccination (n = 14) | Partial vaccination (n = 11) | p1 value | p2 value |
|---|---|---|---|---|---|
| Age—years | 18.0 (17.0–31.0) | 49.5 (39.5–63.8) | 22.0 (18.0–38.0) | <0.001 | 0.316 |
| Female sex | 202 (56.9) | 10 (71.4) | 7 (63.6) | 0.281 | 0.921 |
| Mild cases | 288 (81.1) | 11 (78.6) | 9 (81.8) | 1.000 | 1.000 |
| Moderate cases | 67 (18.9) | 3 (21.4) | 2 (18.2) | 1.000 | 1.000 |
| SARS-CoV-2 shedding period—days | 17.0 (12.0–22.0) | 20.5 (17.8–26.3) | 16.0 (9.0–25.0) | 0.037 | 0.679 |
| Median length of hospital stay—days | 19.0 (15.0–24.0) | 23.0 (19.0–28.3) | 19.0 (15.0–26.0) | 0.056 | 0.981 |
Data are presented as the median (interquartile range) or n (%). SARS-CoV-2 denotes severe acute respiratory syndrome coronavirus 2. p1: fully inactivated vaccination vs. fully recombinant vaccination; p2: fully inactivated vaccination + fully recombinant vaccination vs. partial vaccination.